Symptom Monitoring in Glioma Patients: Development of the Edmonton Symptom Assessment System Glioma Module.

J Neurosci Nurs

Questions or comments about this article may be directed to Margriet IJzerman-Korevaar, MSc RN, at Oncology Nurse, Department of Medical Oncology, Cancer Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Tom J. Snijders, MD PhD, is Neuro-Oncologist, Brain Center Rudolf Magnus, Department of Neurology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Saskia C. C. M. Teunissen, PhD, RN, is Professor, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Alexander de Graeff, MD PhD, is Medical Oncologist, Department of Medical Oncology, Cancer Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Filip Y. F. De Vos, MD, PhD, is Medical Oncologist, Department of Medical Oncology, Cancer Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Published: December 2018

Background And Purpose: Symptoms in glioma patients are distinctly different from symptoms in patients with other types of cancer and have a high impact on quality of life. In this study, a stepwise approach of developing a glioma module for assessment of symptoms, based on a Dutch adapted and validated version of the Edmonton Symptom Assessment System, is described.

Methods: Three phases of instrument development were conducted: a systematic literature review and a focus group interview with experts were performed (phase I) to generate relevant symptoms and construct a preliminary module (phase II). In phase III, the preliminary module was evaluated (n = 25) and pretested (n = 45) in glioma patients representing all phases of the disease.

Results: Our glioma module contains 11 generic and 6 neurologic symptoms. Patients completed the glioma module in a median of 5 minutes, and 56% of the patients required some assistance to complete the instrument.

Conclusion: The glioma module has initial validity and will benefit from prospective validation in a larger cohort of patients with glioma.

Download full-text PDF

Source
http://dx.doi.org/10.1097/JNN.0000000000000400DOI Listing

Publication Analysis

Top Keywords

glioma module
20
glioma patients
12
glioma
9
edmonton symptom
8
symptom assessment
8
assessment system
8
symptoms patients
8
preliminary module
8
patients
7
module
7

Similar Publications

Objective: To assist in the rapid clinical identification of brain tumor types while achieving segmentation detection, this study investigates the feasibility of applying the deep learning YOLOv5s algorithm model to the segmentation of brain tumor magnetic resonance images and optimizes and upgrades it on this basis.

Methods: The research institute utilized two public datasets of meningioma and glioma magnetic resonance imaging from Kaggle. Dataset 1 contains a total of 3,223 images, and Dataset 2 contains 216 images.

View Article and Find Full Text PDF

Dual-path neural network extracts tumor microenvironment information from whole slide images to predict molecular typing and prognosis of Glioma.

Comput Methods Programs Biomed

January 2025

School of Information Science and Technology, Fudan University, Shanghai, 200433, China; Key Laboratory of Medical Imaging, Computing and Computer Assisted Intervention, Shanghai, 200433, China. Electronic address:

Background And Objective: Utilizing AI to mine tumor microenvironment information in whole slide images (WSIs) for glioma molecular subtype and prognosis prediction is significant for treatment. Existing weakly-supervised learning frameworks based on multi-instance learning have potential in WSIs analysis, but the large number of patches from WSIs challenges the effective extraction of key local patch and neighboring patch microenvironment info. Therefore, this paper aims to develop an automatic neural network that effectively extracts tumor microenvironment information from WSIs to predict molecular typing and prognosis of glioma.

View Article and Find Full Text PDF

Understanding the role of personality traits in shaping treatment outcomes is crucial given the multifaceted challenges posed by brain tumors and the significant adverse impact of radiotherapy (RT) on patients' well-being. This study aimed to provide insights into how personality traits affect psychosocial well-being and quality of life during RT in patients with high-grade malignant brain tumors. Personality traits in patients with high-grade glioma were assessed using the Eysenck Personality Questionnaire-Revised (EPQ-R).

View Article and Find Full Text PDF

Deep learning methods have been widely used for various glioma predictions. However, they are usually task-specific, segmentation-dependent and lack of interpretable biomarkers. How to accurately predict the glioma histological grade and molecular subtypes at the same time and provide reliable imaging biomarkers is still challenging.

View Article and Find Full Text PDF

Weakly supervised deep learning-based classification for histopathology of gliomas: a single center experience.

Sci Rep

January 2025

Department of Neurosurgery, West China Hospital, Sichuan University, 37 Guoxue Avenue, Chengdu, 610041, People's Republic of China.

Multiple artificial intelligence systems have been created to facilitate accurate and prompt histopathological diagnosis of tumors using hematoxylin-eosin-stained slides. We aimed to investigate whether weakly supervised deep learning can aid in glioma diagnosis. We analyzed 472 whole slide images (WSIs) from 226 patients in West China Hospital (WCH) and 1604 WSIs from 880 patients in The Cancer Genome Atlas (TCGA).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!